To Improve Adverse Event Tracking, FDA Could Google It

 
• By Derrick Gingery

Teleconference between Google and FDA signals the internet search giant could have a way to improve adverse event detection. The agency calls the talk “a high-level, general discussion” of Google’s capabilities.

One meeting does not a partnership make, but Google’s interest in working with FDA on adverse event tracking should pique interest among those hoping to improve the existing systems.

Peter Lurie, FDA associate commissioner for policy and planning, along with top-level staff from the Office of Surveillance and Epidemiology Director and the Office of Public Health and Analysis conducted a teleconference

More from United States

More from North America